Nichols William Garrett
SEC insider (Form 3/4/5 filer). CIK 0001618364. Chief Medical Officer at Candel Therapeutics, Inc. (CADL). 12 reported Form 4/5 transactions since Sep 2024; latest on Jan 26, 2026. Located in NEEDHAM, MA.
Companies Nichols William Garrett has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Officer, Chief Medical Officer
Nichols William Garrett
CIK: 0001618364
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Candel Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jan 26, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
136.5K shares- - Jul 28, 2025CADL
Candel Therapeutics, Inc.
SaleDirect937 shares at avg. $6.98$7K - Jul 28, 2025CADL
Candel Therapeutics, Inc.
ExerciseDirect937 shares at avg. $1.29$1K - Jun 30, 2025CADL
Candel Therapeutics, Inc.
SaleDirect781 shares at avg. $5.04$4K - Jun 30, 2025CADL
Candel Therapeutics, Inc.
ExerciseDirect781 shares at avg. $1.29$1K - Mar 18, 2025CADL
Candel Therapeutics, Inc.
SaleDirect45.3K shares at avg. $8.76$397K - Mar 18, 2025CADL
Candel Therapeutics, Inc.
ExerciseDirect4.6K shares at avg. $3.75$17K - Mar 18, 2025CADL
Candel Therapeutics, Inc.
ExerciseDirect13.9K shares at avg. $1.29$18K - Feb 12, 2025CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
107.3K shares- - Jan 15, 2025CADL
Candel Therapeutics, Inc.
SaleDirect10.4K shares at avg. $7.22$75K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 26, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 136,500 | - | - | Direct |
| Jul 28, 2025 | CADL Candel Therapeutics, Inc. | Sale | 937 | $6.98 | $6,540 | Direct |
| Jul 28, 2025 | CADL Candel Therapeutics, Inc. | Exercise | 937 | $1.29 | $1,209 | Direct |
| Jun 30, 2025 | CADL Candel Therapeutics, Inc. | Sale | 781 | $5.04 | $3,936 | Direct |
| Jun 30, 2025 | CADL Candel Therapeutics, Inc. | Exercise | 781 | $1.29 | $1,007 | Direct |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | Sale | 45,316 | $8.76 | $396,995 | Direct |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | Exercise | 4,584 | $3.75 | $17,190 | Direct |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | Exercise | 13,905 | $1.29 | $17,937 | Direct |
| Feb 12, 2025 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 107,250 | - | - | Direct |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | Sale | 10,428 | $7.22 | $75,342 | Direct |
1-10 of 12 transactions